Gadot Biochemical Industries has introduced Cal2Mag, a balanced nutraceutical ingredient designed for better menopausal health.
The researched blend of calcium and magnesium citrate was formulated to be highly bioavailable and suitable for supporting women's health.
According to Gadot, Cal2Mag provides a balanced ratio of calcium and magnesium — both of which are cruicial for preventing bone density loss during the menopause.
As well as promoting bone health, the nutraceutical can support the maintenance of cardiovascular health and the muscles.
The ingredient can be used in a range of applications, including functional food and beverages and dietary supplements.
According to the National Menopause Foundation, by 2025, around 1.1 billion women globally will be menopausal — demonstrating the need for products to support this demographic.1
As women age, obtaining a sufficient amount of calcium and magnesium in their diet through food intake and supplements becomes paramount.
Because women in the menopause are at increased risk of osteoporosis and other bone-related issues, ensuring these vital minerals are incorporated into the diet can improve the quality of life and general wellness of female consumers worldwide.
Michael Paikin, Gadot's Chief Technologist, commented: “The citrate form of calcium and magnesium in Cal2Mag ensures superior absorption, independent of stomach acid levels, and can be taken with or without meals. This form also reduces the risk of kidney stones, a common concern with other forms of calcium supplements.”
Reference
1 https://pubmed.ncbi.nlm.nih.gov/25225714/
